To examine whether TChal modified the expression of HSP40 and ATF3 in other cancer cells, HCT-116 (colorectal cancer), FaDu (oral cancer), and SJSA1 (osteosarcoma) cells were treated with TChal at 50 μM for 24 h. This evidence concerns the gene DNAJB1 and lip and oral cavity carcinoma.